Related references
Note: Only part of the references are listed.Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
Takuya Tada et al.
EBIOMEDICINE (2022)
A Novel Computational Approach for the Discovery of Drug Delivery System Candidates for COVID-19
Taeheum Cho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
Cheorl-Ho Kim
FRONTIERS IN PHARMACOLOGY (2021)
Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2
Wenjiang Zheng et al.
FRONTIERS IN PHARMACOLOGY (2021)
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
Sonia Jangra et al.
LANCET MICROBE (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications
Xi Chen et al.
FRONTIERS IN ONCOLOGY (2019)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk A Randomized Clinical Trial
Ji-Young Choi et al.
MEDICINE (2015)
A method for quantifying the unstable and highly polar drug nafamostat mesilate in human plasma with optimized solid-phase extraction and ESI-MS detection: more accurate evaluation for pharmacokinetic study
Yan-guang Cao et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Antiviral activity of glycyrrhizic acid derivatives against SARS - Coronavirus
G Hoever et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Micelle formation and the hydrophobic effect
L Maibaum et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2004)